MMsInc Molecule/ Ligand PDB

Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02485779

You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.

Ligand	Ligand name	Chain	PDB	Tanimoto	Ligand in PDB
Ligand	Ligand name	Chain	PDB	Tanimoto	Ligand in PDB
NOG	13-BETA-ETHYL-17-ALPHA-ETHYNYL- 17-BETA-HYDROXYGON-4-EN-3-ONE	A	1LHV	0.74
NOG	13-BETA-ETHYL-17-ALPHA-ETHYNYL- 17-BETA-HYDROXYGON-4-EN-3-ONE	A,B	3D90	0.74
NDR	(14beta,17alpha)-17-ethynyl-17- hydroxyestr-4-en-3-one	A,B	1SQN	0.74
NDR	(14beta,17alpha)-17-ethynyl-17- hydroxyestr-4-en-3-one	A,B	2W8Y	0.74
17H	17-HYDROXY-18A-HOMO-19-NOR-17ALPHA- PREGNA-4,9,11-TRIEN-3-ONE	A	2AMB	0.74
8PG	(8S,12S)-15S-HYDROXY-9-OXOPROSTA- 10Z,13E-DIEN-1-OIC ACID	A,B	2G5W	0.71
CBO	CARBENOXOLONE	A,B,C,D	1HDC	0.7
CBO	CARBENOXOLONE	A,B,C,D	2BEL	0.7
20E	(2beta,3beta,5beta,22R)-2,3,14,20,22,25- hexahydroxycholest-7-en-6-one	A,D	2R40	0.72
1CA	DESOXYCORTICOSTERONE	A,B	1Y9R	0.74
1CA	DESOXYCORTICOSTERONE	A,B,C	2ABI	0.74
1CA	DESOXYCORTICOSTERONE	A	2Q3Y	0.74
1CA	DESOXYCORTICOSTERONE	A	2AA7	0.74
CA4	CYPROTERONE ACETATE	A	2OZ7	0.71
GR3	3-ACETOXY-17-(1-FORMYL-5-METHYL- 3-OXO-HEX-4-ENYL)-16-HYDROXY-4,10,13,14- TETRAMETHYL-2,3,4,5,6,9,10,11,12,13,14,15,16,17- TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHRENE- 4-CARBOXYLIC ACID	B,D	1AWH	0.71
ASD	4-ANDROSTENE-3-17-DIONE	A,B	3CAS	0.73
ASD	4-ANDROSTENE-3-17-DIONE	A	1QYX	0.73
ASD	4-ANDROSTENE-3-17-DIONE	A,B,C,D	2VCT	0.73
ASD	4-ANDROSTENE-3-17-DIONE	A	1EUP	0.73
ASD	4-ANDROSTENE-3-17-DIONE	A,B,C,D,E,F, G,H,I,J,K,L, M,N,O,P	2VCV	0.73
ASD	4-ANDROSTENE-3-17-DIONE	A	3EQM	0.73
ASD	4-ANDROSTENE-3-17-DIONE	A	1XF0	0.73
FUA	FUSIDIC ACID	A	1QCA	0.71
FUA	FUSIDIC ACID	A,B,C,D,E,F, G,H,I,J,K,L	1Q23	0.71
FUA	FUSIDIC ACID	A,B	2VUF	0.71
2OB	CHOLESTERYL OLEATE	A	2OBD	0.78
ANB	ANDROSTA-1,4-DIENE-3,17-DIONE	A	1H62	0.74
CLL	CHOLESTERYL LINOLEATE	A,B	1CLE	0.78
C0R	CORTICOSTERONE	A	2A3I	0.72
C0R	CORTICOSTERONE	A,B	1Y5R	0.72
1PL	(1S,3aS,5aR,8aS)-1,7,7-trimethyl- 1,2,3,3a,5a,6,7,8-octahydrocyclopenta[c]pentalene- 4-carboxylic acid	A	2RDS	0.73
1PL	(1S,3aS,5aR,8aS)-1,7,7-trimethyl- 1,2,3,3a,5a,6,7,8-octahydrocyclopenta[c]pentalene- 4-carboxylic acid	A	2RDN	0.73
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A,B	1E3R	0.72
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	3DHE	0.72
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	1J99	0.72
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	1COY	0.72
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	1Q22	0.72
FFA	(10ALPHA,13ALPHA,14BETA,17ALPHA)- 17-HYDROXYANDROST-4-EN-3-ONE	A,B	2IPG	0.74
FFA	(10ALPHA,13ALPHA,14BETA,17ALPHA)- 17-HYDROXYANDROST-4-EN-3-ONE	A,B	2IPJ	0.74
FFA	(10ALPHA,13ALPHA,14BETA,17ALPHA)- 17-HYDROXYANDROST-4-EN-3-ONE	A,B	2IPF	0.74
NTH	SUCCINIC ACID MONO-(13-METHYL-3- OXO-2,3,6,7,8,9,10,11,12,13,14,15,16,17- TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN- 17-YL) ESTER	A,B	1BUQ	0.76
CBW	(3BETA,5BETA,14BETA)-3-HYDROXY- 11-OXOOLEAN-12-EN-29-OIC ACID	A	2W4Q	0.74